Semaphorins and their receptors in stem and cancer cells

Current Medicinal Chemistry

Volumn 17, Issue 30, 2010, Pages 3462-3475

  Micucci, C ^a,b   Orciari, S ^a   Catalano, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Cancer cells; Plexins; Semaphorins; Stem cells; Tumor progression

Indexed keywords

NEUROPILIN; SEMAPHORIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MORPHOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TUMOR VASCULARIZATION;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; MICE; NEOPLASTIC STEM CELLS; NEUROPILINS; RECEPTORS, CELL SURFACE; SEMAPHORINS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77957937088     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710792927796     Document Type: Article

References (118)

1. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells,cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
2. Yazdani, U.; Terman, J.R. The semaphorins. Genome Biol., 2006,7, 211.
3. Luo, Y.; Raible, D.; Raper, J.A. Collapsin: a protein in brain thatinduces the collapse and paralysis of neuronal growth cones. Cell,1993, 75, 217-227.
4. Roffers-Agarwal, J. and Gammill, L.S. Neuropilin receptors guidedistinct phases of sensory and motor neuronal segmentation. Development,2009, 136, 1879-1888.
5. Gonthier, B.; Nasarre, C.; Roth, L.; Perraut, M.; Thomasset, N.; Roussel, G.; Aunis, D.; Bagnard, D. Functional interaction betweenmatrix metalloproteinase-3 and semaphorin-3C during cortical axonalgrowth and guidance. Cereb. Cortex., 2007, 17, 1712-1721.
6. Song, H.; Ming, G.; He, Z.; Lehmann, M.; McKerracher, L.; Tessier-Lavigne, M.; Poo, M. Conversion of neuronal growth coneresponses from repulsion to attraction by cyclic nucleotides. Science,1998, 281, 1515-1518.
7. Kikutani, H.; Kumanogoh, A. Semaphorins in interactions betweenT cells and antigen-presenting cells. Nat. Rev. Immunol., 2003, 3,159-167.
8. Shi, W.; Kumanogoh, A.; Watanabe, C.; Uchida, J.; Wang, X.; Yasui, T.; Yukawa, K.; Ikawa, M.; Okabe, M.; Parnes, J.R.; Yoshida, K.; Kikutani, H. The class IV semaphorin CD100 plays nonredundantroles in the immune system: defective B and T cell activationin CD100-deficient mice. Immunity, 2000, 13, 633-642.
9. Pasterkamp, R.J.; Peschon, J.J.; Spriggs, M.K.; Kolodkin, A.L.Semaphorin 7A promotes axon outgrowth through integrins andMAPKs. Nature, 2003, 424, 398-405.
10. Suzuki, K.; Okuno, T.; Yamamoto, M.; Pasterkamp, R.J.; Takegahara, N.; Takamatsu, H.; Kitao, T.; Takagi, J.; Rennert, P.D.; Kolodkin, A.L.; Kumanogoh, A.; Kikutani, H. Semaphorin 7A initiatesT-cell-mediated inflammatory responses through alpha1beta1integrin. Nature, 2007, 446, 680-684.
11. Toyofuku, T.; Zhang, H.; Kumanogoh, A.; Takegahara, N.; Yabuki, M.; Harada, K.; Hori, M.,; Kikutani, H. Guidance of myocardialpatterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol., 2004, 6, 1204-1211.
12. Eckhardt, F.; Behar, O.; Calautti, E.; Yonezawa, K.; Nishimoto, I.; Fishman, M.C. A novel transmembrane semaphorin can bind c-src.Mol. Cell Neurosci., 1997, 9, 409-419.
13. Comoglio, P.M.; Tamagnone, L.; Giordano, S. Invasive growth: atwo-way street for semaphorin signalling. Nat. Cell Biol., 2004, 6,1155-1157.
14. Conrotto, P.; Corso, S.; Gamberini, S.; Comoglio, P.M.; Giordano, S. Interplay between scatter factor receptors and B plexins controlsinvasive growth. Oncogene, 2004, 23, 5131-5137.
15. Giordano, S.; Corso, S.; Conrotto, P.; Artigiani, S.; Gilestro, G.; Barberis, D.; Tamagnone, L.; Comoglio, P.M. The semaphorin 4Dreceptor controls invasive growth by coupling with Met. Nat. CellBiol., 2002, 4, 720-724.
16. Swiercz, J.M.; Worzfeld, T.; Offermanns, S. ErbB-2 and met reciprocallyregulate cellular signaling via plexin-B1. J. Biol. Chem.,2008, 283, 1893-1901.
17. Franco, M.; Tamagnone, L. Tyrosine phosphorylation in semaphorinsignalling: shifting into overdrive. EMBO Rep., 2008, 9,865-871.
18. Mitsui, N.; Inatome, R.; Takahashi, S.; Goshima, Y.; Yamamura, H.; Yanagi, S. Involvement of Fes/Fps tyrosine kinase in semaphorin3Asignaling. EMBO J., 2002, 21, 3274-3285.
19. Bechara, A.; Nawabi, H.; Moret, F.; Yaron, A.; Weaver, E.; Bozon, M.; Abouzid, K.; Guan, J.L.; Tessier-Lavigne, M.; Lemmon, V.;Castellani, V. FAK-MAPK-dependent adhesion disassemblydownstream of L1 contributes to semaphorin3A-induced collapse.EMBO J., 2008, 27, 1549-1562.
20. Neufeld, G.; Kessler, O. The semaphorins: versatile regulators oftumour progression and tumour angiogenesis. Nat. Rev. Cancer,2008, 8, 632-645.
21. Ji, J.D.; Ivashkiv, L.B. Roles of semaphorins in the immune andhematopoietic system. Rheumatol. Int., 2009, 29, 727-734.
22. Koncina, E.; Roth, L.; Gonthier, B.; Bagnard, D. Role of semaphorinsduring axon growth and guidance. Adv. Exp. Med. Biol.,2007, 621, 50-64.
23. Halloran, M.C.; Wolman, M.A. Repulsion or adhesion: receptorsmake the call. Curr. Opin. Cell. Biol., 2006, 18, 533-540.
24. Serini, G.; Napione, L.; Bussolino, F. Integrins team up with tyrosinekinase receptors and plexins to control angiogenesis. Curr.Opin. Hematol., 2008, 15, 235-242.
25. Casazza, A.; Fazzari, P.; Tamagnone, L. Semaphorin signals in celladhesion and cell migration: functional role and molecular mechanisms.Adv. Exp. Med. Biol., 2007, 600, 90-108.
26. Püschel AW. GTPases in semaphorin signaling Adv. Exp. Med.Biol., 2007, 600, 12-23.
27. Guo, W.; Pylayeva, Y.; Pepe, A.; Yoshioka, T.; Muller, W.J.; Inghirami, G.; Giancotti, F.G. Beta 4 integrin amplifies ErbB2 signalingto promote mammary tumorigenesis. Cell, 2006, 126, 489-502.
28. Trusolino, L.; Bertotti, A.; Comoglio, P.M. A signaling adapterfunction for alpha6beta4 integrin in the control of HGF-dependentinvasive growth. Cell, 2001, 107, 643-654.
29. Ito, Y.; Oinuma, I.; Katoh, H.; Kaibuchi, K.; Negishi, M. Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity,inducing growth cone collapse. EMBO Rep., 2006, 7, 704-709.
30. Basile, J.R.; Afkhami, T.; Gutkind, J.S. Semaphorin 4D/plexin-B1induces endothelial cell migration through the activation of PYK2,Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol. CellBiol., 2005, 25, 6889-6898.
31. Basile, J.R.; Gavard, J.; Gutkind, J.S. Plexin-B1 utilizes RhoA andRho kinase to promote the integrin-dependent activation of Akt andERK and endothelial cell motility. J. Biol. Chem., 2007, 282,34888-34895.
32. Roth, L.; Koncina, E.; Satkauskas, S.; Crémel, G.; Aunis, D.; Bagnard, D. The many faces of semaphorins: from development topathology. Cell Mol. Life Sci., 2009, 66, 649-666.
33. Toyofuku, T.; Kikutani, H. Semaphorin signaling during cardiacdevelopment. Adv. Exp. Med. Biol., 2007, 600, 109-117.
34. Kagoshima, M.; Ito, T. Diverse gene expression and function ofsemaphorins in developing lung: positive and negative regulatoryroles of semaphorins in lung branching morphogenesis. GenesCells, 2001, 6, 559-571.
35. Ito, T.; Kagoshima, M.; Sasaki, Y.; Li, C.; Udaka, N.; Kitsukawa, T.; Fujisawa, H.; Taniguchi, M.; Yagi, T.; Kitamura, H.; Goshima,Y. Repulsive axon guidance molecule Sema3A inhibits branchingmorphogenesis of fetal mouse lung. Mech. Dev., 2000, 97, 35-45.
36. Yu, Z.; Kryzer, T.J.; Griesmann, G.E.; Kim, K.; Benarroch, E.E.; Lennon, V.A. CRMP-5 neuronal autoantibody: marker of lung cancerand thymoma-related autoimmunity. Ann. Neurol., 2001, 49,146-154.
37. Roche, J.; Boldog, F.; Robinson, M.; Varella-Garcia, M.; Swanson, M.; Waggoner, B.; Fishel, R.; Franklin, W.; Gemmill, R.; Drabkin,H. Distinct 3p21.3 deletions in lung cancer and identification of anew human semaphorin. Oncogene, 1996, 12, 1289-1297.
38. Xiang, R.H.; Hensel, C.H.; Garcia, D.K.; Carlson, H.C.; Kok, K.; Daly, M.C.; Kerbacher, K.; Berg, A.V.D.; Veldhuis, P.; Buys, C.H.C.M.; Naylor, S.L. Isolation of the human semaphorin III/Fgene (SEMA3F) at chromosome 3p21.3, a region deleted in lungcancer. Genomics, 1996, 32, 39-48.
39. Lamont, R.E.; Lamont, E.J.; Childs, S.J. Antagonistic interactionsamong Plexins regulate the timing of intersegmental vessel formation.Dev. Biol., 2009, 331, 199-209.
40. Cimato, T.; Beers, J.; Ding, S.; Ma, M.; McCoy, J.P.; Boehm, M.; Nabel, E.G. Neuropilin-1 identifies endothelial precursors in humanand murine embryonic stem cells before CD34 expression. Circulation, 2009, 119, 2170-2178.
41. Behar, O.; Golden, J.A.; Mashimo, H.; Schoen, F.J.; Fishman, M.C. Semaphorin III is needed for normal patterning and growth ofnerves, bones and heart. Nature, 1996, 383, 525-528.
42. Sahay, A.; Molliver, M.E.; Ginty, D.D.; Kolodkin, A.L. Semaphorin3F is critical for development of limbic system circuitry andis required in neurons for selective CNS axon guidance events. J.Neurosci., 2003, 23, 6671-6680.
43. Taniguchi, M.; Yuasa, S.; Fujisawa, H.; Naruse, I.; Saga, S.; Mishina, M.; Yagi, T. Disruption of semaphorin III/D gene causessevere abnormality in peripheral nerve projection. Neuron, 1997,19, 519-530.
44. Schwarting, G.A.; Kostek, C.; Ahmad, N.; Dibble, C.; Pays, L.; Püschel, A.W. Semaphorin 3A is required for guidance of olfactoryaxons in mice. J. Neurosci., 2000, 20, 7691-7697.
45. Gu, C.; Rodriguez, E.R.; Reimert, D.V.; Shu, T.; Fritzsch, B.; Richards, L.J.; Kolodkin, A.L.; Ginty, D.D. Neuropilin-1 conveyssemaphorin and VEGF signaling during neural and cardiovasculardevelopment. Dev. Cell, 2003, 5, 45-57.
46. Serini, G.; Valdembri, D.; Zanivan, S.; Morterra, G.; Burkhardt, C.; Caccavari, F.; Zammataro, L.; Primo, L.; Tamagnone, L.; Logan, M.; Tessier-Lavigne, M.; Taniguchi, M.; Püschel, A.W.; Bussolino, F. Class 3 semaphorins control vascular morphogenesis by inhibitingintegrin function. Nature, 2003, 424, 391-397.
47. Feiner, L.; Webber, A.L.; Brown, C.B.; Lu, M.M.; Jia, L.; Feinstein, P.; Mombaerts, P.; Epstein, J.A.; Raper, J.A. Targeted disruptionof semaphorin 3C leads to persistent truncus arteriosus andaortic arch interruption. Development, 2001, 128, 3061-3070.
48. Fiore, R.; Püschel, A.W. The function of semaphorins during nervoussystem development. Front. Biosci., 2003, 8, 484-499.
49. Gitler, A.D.; Lu, M.M.; Epstein, J.A. PlexinD1 and semaphorinsignaling are required in endothelial cells for cardiovascular development.Dev. Cell., 2004, 7, 107-116.
50. Tatsumi, R.; Sankoda, Y.; Anderson, J.E.; Sato, Y.; Mizunoya, W.; Shimizu, N.; Suzuki, T.; Yamada, M.; Rhoads, R.P. Jr; Ikeuchi, Y.; Allen, R.E. Possible implication of satellite cells in regenerativemotoneuritogenesis: HGF upregulates neural chemorepellentSema3A during myogenic differentiation. Am. J. Physiol. CellPhysiol., 2009, 297, 238-252.
51. Ko, J.A.; Morishige, N.; Yanai, R.; Nishida, T. Up-regulation ofsemaphorin 3A in human corneal fibroblasts by epidermal growthfactor released from cocultured human corneal epithelial cells. Biochem.Biophys. Res. Commun., 2008, 377, 104-108.
52. Wong, A.W.; Brickey, W.J.; Taxman, D.J.; van Deventer, H.W.; Reed, W.; Gao, J.X.; Zheng, P., Liu, Y.; Li, P.; Blum, J.S.; McKinnon, K.P.; Ting, J.P. CIITA-regulated plexin-A1 affects Tcell-dendritic cell interactions. Nat. Immunol., 2003, 4, 891-898.
53. Takegahara, N.; Takamatsu, H.; Toyofuku, T.; Tsujimura, T.; Okuno, T.; Yukawa, K.; Takegahara, N.; Mizui, M.; Yamamoto, M.; Prasad, D.V.; Suzuki, K.; Ishii, M.; Terai, K.; Moriya, M.; Nakatsuji, Y.; Sakoda, S.; Sato, S.; Akira, S.; Takeda, K.; Inui, M.; Takai, T.; Ikawa, M.; Okabe, M.; Kumanogoh, A.; Kikutani, H. Plexin-A1 and its interaction with DAP12 in immune responsesand bone homeostasis. Nat. Cell Biol., 2006, 8, 615-622.
54. O'Connor, B.P.; Eun, S.Y.; Ye, Z.; Zozulya, A.L.; Lich, J.D.; Moore, C.B.; Iocca, H.A.; Roney, K.E.; Holl, E.K.; Wu, Q.P.; vanDeventer, H.W.; Fabry, Z.; Ting, J.P. Semaphorin 6D regulates thelate phase of CD4+ T cell primary immune responses. Proc. Natl.Acad. Sci. U.S.A., 2008, 105, 13015-13020.
55. Catalano, A.; Caprari, P.; Moretti, S.; Faronato, M.; Tamagnone, L.; Procopio, A. Semaphorin-3A is expressed by tumor cells andalters T-cell signal transduction and function. Blood, 2006, 107,3321-3329.
56. Moretti, S.; Procopio, A.; Lazzarini, R.; Rippo, M.R.; Testa, R.; Marra, M.; Tamagnone, L.; Catalano, A. Semaphorin3A signalingcontrols Fas (CD95)-mediated apoptosis by promoting Fas translocationinto lipid rafts. Blood, 2008, 111, 2290-2299.
57. Delaire, S.; Billard, C.; Tordjman, R.; Chedotal, A.; Elhabazi, A.; Bensussan, A.; Boumsell, L. Biological activity of soluble CD100.II. Soluble CD100, similarly to H-SemaIII, inhibits immune cellmigration. J. Immunol., 2001, 166, 4348-4354.
58. Vincent, P.; Collette, Y.; Marignier, R.; Vuaillat, C.; Rogemond, V.; Davoust, N.; Malcus, C.; Cavagna, S.; Gessain, A.; Machuca-Gayet, I.; Belin, M.F.; Quach, T.; Giraudon, P. A role for the neuronalprotein collapsin response mediator protein 2 in T lymphocytepolarization and migration. J. Immunol., 2005, 175, 7650-7660.
59. Pellet-Many, C.; Frankel, P.; Jia, H.; Zachary, I. Neuropilins: structure,function and role in disease. Biochem. J., 2008, 411, 211-226.
60. Marcus, K.; Johnson, M.; Adam, R.M.; O'Reilly, M.S.; Donovan, M.; Atala, A.; Freeman, M.R.; Soker, S. Tumor cell-associatedneuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology.,2005, 25, 178-187.
61. Rieger, J.; Wick, W.; Weller, M. Human malignant glioma cellsexpress semaphorins and their receptors, neuropilins and plexins.Glia., 2003, 42, 379-389.
62. Ghosh, S.; Sullivan, C.A.; Zerkowski, M.P.; Molinaro, A.M.; Rimm, D.L.; Camp, R.L.; Chung, G.G. High levels of vascular endothelialgrowth factor and its receptors (VEGFR-1, VEGFR-2,neuropilin-1) are associated with worse outcome in breast cancer.Hum. Pathol., 2008, 39, 1835-1843.
63. Hansel, D.E.; Wilentz, R.E.; Yeo, C.J.; Schulick, R.D.; Montgomery, E.; Maitra, A. Expression of neuropilin-1 in highgradedysplasia, invasive cancer, and metastases of the human gastrointestinaltract. Am. J. Surg. Pathol., 2004, 28, 347-356.
64. Osada, H.; Tokunaga, T.; Nishi, M.; Hatanaka, H.; Abe, Y.; Tsugu, A.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Nakamura, M. Overexpressionof the neuropilin 1 (NRP1) gene correlated with poorprognosis in human glioma. Anticancer. Res., 2004, 24, 547-552.
65. Latil, A.; Bièche, I.; Pesche, S.; Valéri, A.; Fournier, G.; Cussenot, O.; Lidereau, R. VEGF overexpression in clinically localized prostatetumors and neuropilin-1 overexpression in metastatic forms.Int. J. Cancer, 2000, 89, 167-171.
66. Miao, H.Q.; Lee, P.; Lin, H.; Soker, S.; Klagsbrun, M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J., 2000, 14, 2532-2539.
67. Bachelder, R.E.; Lipscomb, E.A.; Lin, X.; Wendt, M.A.; Chadborn, N.H.; Eickholt, B.J.; Mercurio, A.M. Competing autocrine pathwaysinvolving alternative neuropilin-1 ligands regulate chemotaxisof carcinoma cells. Cancer Res., 2003, 63, 5230-5233.
68. Handa, A.; Tokunaga, T.; Tsuchida, T.; Lee, Y.H.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Fukuda, H.; Nakamura, M. Neuropilin-2 expression affects the increased vascularization and is a prognosticfactor in osteosarcoma. Int. J. Oncol., 2000, 17, 291-295.
69. Dallas, N.A.; Gray, M.J.; Xia, L.; Fan, F.; Van Buren, G. 2nd; Gaur, P.; Samuel, S.; Lim, S.J.; Arumugam, T.; Ramachandran, V.; Wang, H.; Ellis, L.M. Neuropilin-2-mediated tumor growth andangiogenesis in pancreatic adenocarcinoma. Clin. Cancer Res.,2008, 14, 8052-8060.
70. Gray, M.J.; Van Buren, G.; Dallas, N.A.; Xia, L.; Wang, X.; Yang, A.D.; Somcio, R.J.; Lin, Y.G.; Lim, S.; Fan, F.; Mangala, L.S.; Arumugam, T.; Logsdon, C.D.; Lopez-Berestein, G.; Sood, A.K.; Ellis, L.M. Therapeutic targeting of neuropilin-2 on colorectal carcinomacells implanted in the murine liver. J. Natl. Cancer Inst.,2008, 100, 109-120.
71. Gray, M.J.; Wey, J.S.; Belcheva, A.; McCarty, M.F.; Trevino, J.G.; Evans, D.B.; Ellis, L.M.; Gallick, G.E. Neuropilin-1 suppressestumorigenic properties in a human pancreatic adenocarcinomacell line lacking neuropilin-1 coreceptors. Cancer Res., 2005,65, 3664-3670.
72. Kamiya, T.; Kawakami, T.; Abe, Y.; Nishi, M.; Onoda, N.; Miyazaki, N.; Oida, Y.; Yamazaki, H.; Ueyama, Y.; Nakamura, M. The preserved expression of neuropilin (NRP) 1 contributes to abetter prognosis in colon cancer. Oncol. Rep., 2006, 15, 369-373.
73. Syed, V.; Zhang, X.; Lau, K.M.; Cheng, R.; Mukherjee, K.; Ho, S.M. Profiling estrogen-regulated gene expression changes in normaland malignant human ovarian surface epithelial cells. Oncogene,2005, 24, 8128-8143.
74. Zhao, X.Y.; Chen, L.; Li, Y.H.; Xu, Q. PlexinA1 expression ingastric carcinoma and its relationship with tumor angiogenesis andproliferation. World J. Gastroenterol., 2007, 13, 6558-6561.
75. Wong, O.G.; Nitkunan, T.; Oinuma, I.; Zhou, C.; Blanc, V.; Brown, R.S.; Bott, S.R.; Nariculam, J.; Box, G.; Munson, P.; Constantinou, J.; Feneley, M.R.; Klocker, H.; Eccles, S.A.; Negishi, M.; Freeman, A.; Masters, J.R.; Williamson, M. Plexin-B1mutations in prostate cancer. Proc. Natl. Acad. Sci. U. S. A., 2007,104, 19040-19045.
76. Gómez Román, J.J.; Garay, G.O.; Saenz, P.; Escuredo, K.; SanzIbayondo, C.; Gutkind, S.; Junquera, C.; Simón, L.; Martínez, A.; Fernández Luna, J.L.; Val-Bernal, J.F. Plexin B1 is downregulatedin renal cell carcinomas and modulates cell growth. Transl. Res.,2008, 151, 134-140.
77. Rody, A.; Holtrich, U.; Gaetje, R.; Gehrmann, M.; Engels, K.; vonMinckwitz, G.; Loibl, S.; Diallo-Danebrock, R.; Ruckhäberle, E.; Metzler, D.; Ahr, A.; Solbach, C.; Karn, T.; Kaufmann, M. Poor outcome in estrogen receptor-positive breast cancers predicted byloss of plexin B1. Clin. Cancer Res., 2007, 13, 1115-1122.
78. Scott, G.A.; McClelland, L.A.; Fricke, A.F.; Fender, A. Plexin C1,a receptor for semaphorin 7a, inactivates cofilin and is a potentialtumor suppressor for melanoma progression. J. Invest. Dermatol.,2009, 129, 954-963.
79. Kigel, B., Varshavsky, A., Kessler, O., Neufeld, G. Successfulinhibition of tumor development by specific class-3 semaphorins isassociated with expression of appropriate semaphorin receptors bytumor cells. PLoS One, 2008, 3(9), e3287.
80. Roodink, I.; Raats, J.; van der Zwaag, B.; Verrijp, K.; Kusters, B.; van Bokhoven, H.; Linkels, M.; de Waal, R.M.; Leenders, W.P. Plexin D1 expression is induced on tumor vasculature and tumorcells: a novel target for diagnosis and therapy? Cancer Res., 2005,65, 8317-8323.
81. Roodink, I.; Kats, G.; van Kempen, L.; Grunberg, M.; Maass, C.; Verrijp, K.; Raats, J.; Leenders, W. Semaphorin 3E expression correlatesinversely with Plexin D1 during tumor progression. Am. J.Pathol., 2008, 173, 1873-1881.
82. Tomizawa, Y.; Sekido, Y.; Kondo, M.; Gao, B.; Yokota, J.; Roche, J.; Drabkin, H.; Lerman, M.I.; Gazdar, A.F.; Minna, J.D. Inhibitionof lung cancer cell growth and induction of apoptosis after reexpressionof 3p21.3 candidate tumor suppressor gene SEMA3B.Proc. Natl. Acad. Sci. U.S A., 2001, 98, 13954-13959.
83. Bielenberg, D.R.; Hida, Y.; Shimizu, A.; Kaipainen, A.; Kreuter, M.; Kim, C.C.; Klagsbrun, M. Semaphorin 3F, a chemorepulsantfor endothelial cells, induces a poorly vascularized, encapsulated,nonmetastatic tumor phenotype. J. Clin. Invest., 2004, 114, 1260-1271.
84. Futamura, M.; Kamino, H.; Miyamoto, Y.; Kitamura, N.; Nakamura, Y.; Ohnishi, S.; Masuda, Y.; Arakawa, H. Possible roleof semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, inp53-regulated tumor angiogenesis suppression. Cancer Res., 2007,67, 1451-1460.
85. Basile, J.R.; Castilho, R.M.; Williams, V.P.; Gutkind, J.S. Semaphorin4D provides a link between axon guidance processes andtumor-induced angiogenesis. Proc. Natl. Acad. Sci. U.S.A., 2006,103, 9017-9022.
86. Chabbert-de Ponnat, I.; Buffard, V.; Leroy, K.; Bagot, M.; Bensussan, A.; Wolkenstein, P.; Marie-Cardine, A. Antiproliferativeeffect of semaphorin 3F on human melanoma cell lines. J. Invest.Dermatol., 2006, 126, 2343-2345.
87. Pan, G.Q.; Lv, H.; Ren, H.Z.; Wang, Y.; Liu, Y.; Jiang, H.; Wen, J. Elevated expression of semaphorin 5A in human gastric cancer andits implication in carcinogenesis. Life Sci., 2010, 86, 139-144.
88. Pan, G.Q.; Ren, H.Z.; Zhang, S.F.; Wang, X.M.; Wen, J.F. Expressionof semaphorin 5A and its receptor plexin B3 contributes to invasionand metastasis of gastric carcinoma. World J. Gastroenterol.,2009, 15, 2800-2804.
89. Herman, J.G.; Meadows, G.G. Increased class 3 semaphorin expressionmodulates the invasive and adhesive properties of prostatecancer cells. Int. J. Oncol., 2007, 30, 1231-1238.
90. Nguyen, Q.D.; Rodrigues, S.; Rodrigue, C.M.; Rivat, C.; Grijelmo, C.; Bruyneel, E.; Emami, S.; Attoub, S.; Gespach, C. Inhibition ofvascular endothelial growth factor (VEGF)-165 and semaphorin3A-mediated cellular invasion and tumor growth by the VEGF signalinginhibitor ZD4190 in human colon cancer cells andxenografts. Mol. Cancer Ther., 2006, 5, 2070-2077.
91. Catalano, A.; Caprari, P.; Rodilossi, S.; Betta, P.; Castellucci, M.; Casazza, A.; Tamagnone, L.; Procopio, A. Cross-talk between vascularendothelial growth factor and semaphorin-3A pathway in theregulation of normal and malignant mesothelial cell proliferation.FASEB J., 2004, 18, 358-360.
92. Basile, J.R.; Barac, A.; Zhu, T.; Guan, K.L.; Gutkind, J.S. Class IVsemaphorins promote angiogenesis by stimulating Rho-initiatedpathways through plexin-B. Cancer Res., 2004, 64, 5212-5224.
93. Gilbert, S.F. Ageing and cancer as diseases of epigenesis. J. Biosci.,2009, 34, 601-604.
94. Bell, D.W. Our changing view of the genomic landscape of cancer.J. Pathol., 2010, 220, 231-243.
95. Pardal, R.; Clarke, M.F.; Morrison, S.J. Applying the principles ofstem-cell biology to cancer. Nat. Rev. Cancer, 2003, 3, 895-902.
96. Hochedlinger, K.; Jaenisch, R. Nuclear reprogramming and pluripotency.Nature, 2006; 441, 1061-7.
97. Reya, T.; Clevers, H. Wnt signaling in stem cells and cancer. Nature,2005, 434, 843-850.
98. Clarke, D.L.; Johansson, C.B.; Wilbertz, J.; Veress, B.; Nilsson, E.; Karlström, H.; Lendahl, U.; Frisén, J. Generalized potential of adultneural stem cells. Science, 2000, 288, 1660-1663.
99. Wang, Z.; Li, Y.; Wu, X.; Cheng, S.; Yang, L.; Wu, Y. KDR andSema3 genes expression in bone marrow stromal cells and hematopoieticcells from leukemia patients and normal individuals.Hematology, 2005, 10, 307-312.
100. Piccirillo, S.G.; Binda, E.; Fiocco, R.; Vescovi, A.L.; Shah, K. Brain cancer stem cells. J.Mol. Med., 2009, 87, 1087-1095.
101. Bagci, T.; Wu, J.K.; Pfannl, R.; Ilag, L.L.; Jay, D.G. Autocrinesemaphorin 3A signaling promotes glioblastoma dispersal.Oncogene, 2009, 28, 3537-3550.
102. Yamada, T.; Endo, R.; Gotoh, M.; Hirohashi, S. Identification ofsemaphorin E as a non-MDR drug resistance gene of human cancers.Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 14713-14718.
103. Kawasaki, T.; Bekku, Y.; Suto, F.; Kitsukawa, T.; Taniguchi, M.; Nagatsu, I.; Nagatsu, T.; Itoh, K.; Yagi, T.; Fujisawa, H.Requirement of neuropilin 1-mediated Sema3A signals in patterningof the sympathetic nervous system. Development, 2002, 129,671-680.
104. Tao, Y.; Black, I.B.; DiCicco-Bloom, E. In vivo neurogenesis isinhibited by neutralizing antibodies to basic fibroblast growth factor.J. Neurobiol., 1997, 33, 289-296.
105. Kuhn, H.G.; Winkler, J.; Kempermann, G.; Thal, L.J.; Gage, F.H. Epidermal growth factor and fibroblast growth factor-2 have differenteffects on neural progenitors in the adult rat brain. J. Neurosci.,1997, 17, 5820-5829.
106. Chadborn, N.H.; Ahmed, A.I.; Holt, M.R.; Prinjha, R.; Dunn, G.A.; Jones, G.E.; Eickholt, B.J. PTEN couples Sema3A signalling togrowth cone collapse. J. Cell Sci., 2006, 119, 951-957.
107. Otaegi, G.; Yusta-Boyo, M.J.; Vergaño-Vera, E.; Méndez-Gómez, H.R.; Carrera, A.C.; Abad, J.L.; González, M.; de la Rosa, E.J.; Vicario-Abejón, C.; de Pablo, F. Modulation of the PI 3-kinase-Aktsignalling pathway by IGF-I and PTEN regulates the differentiationof neural stem/precursor cells. J. Cell Sci., 2006, 119, 2739-2748.
108. Jiang, B.H.; Aoki, M.; Zheng, J.Z.; Li, J.; Vogt, P.K. Myogenicsignaling of phosphatidylinositol 3-kinase requires the serinethreoninekinase Akt/protein kinase B. Proc. Natl. Acad. Sci.U.S.A., 1999, 96, 2077-2081.
109. Holmen, S.L.; Williams, B.O. Essential role for Ras signaling inglioblastoma maintenance. Cancer Res., 2005, 65, 8250-8255.
110. Pauling, M.H.; Vu, T.H. Mechanisms and regulation of lung vasculardevelopment. Curr. Top. Dev. Biol., 2004, 64, 73-99.
111. Westhoff, B.; Colaluca, I.N.; D'Ario, G.; Donzelli, M.; Tosoni, D.; Volorio, S.; Pelosi, G.; Spaggiari, L.; Mazzarol, G.; Viale, G.; Pece, S.; Di Fiore, P.P. Alterations of the Notch pathway in lungcancer. Proc. Natl. Acad. Sci. U.S.A., 2009, 106, 22293-22298.
112. Neufeld, G.; Shraga-Heled, N.; Lange, T.; Guttmann-Raviv, N.; Herzog, Y.; Kessler, O. Semaphorins in cancer. Front. Biosci.,2005, 10, 751-760.
113. Perälä, N.M.; Immonen, T.; Sariola, H. The expression of plexinsduring mouse embryogenesis. Gene Expr. Patterns., 2005, 5, 355-362.
114. Espada, J.; Calvo, M.B.; Díaz-Prado, S.; Medina, V. Wnt signallingand cancer stem cells. Clin. Transl. Oncol., 2009, 11, 411-427.
115. Rosen, J.M.; Jordan, C.T. The increasing complexity of the cancerstem cell paradigm. Science, 2009, 324, 1670-1673.
116. Bao, S.; Wu, Q.; Sathornsumetee, S.; Hao, Y.; Li, Z.; Hjelmeland, A.B.; Shi, Q.; McLendon, R.E.; Bigner, D.D.; Rich, J.N. Stem celllikeglioma cells promote tumor angiogenesis through vascular endothelialgrowth factor. Cancer Res., 2006, 66, 7843-7848.
117. Maione, F.; Molla, F.; Meda, C.; Latini, R.; Zentilin, L.; Giacca, M.; Seano, G.; Serini, G.; Bussolino, F.; Giraudo, E. Semaphorin3A is an endogenous angiogenesis inhibitor that blocks tumorgrowth and normalizes tumor vasculature in transgenic mousemodels. J. Clin. Invest., 2009, 119, 3356-3372.
118. Vacca, A.; Scavelli, C.; Serini, G.; Di Pietro, G.; Cirulli, T.; Merchionne, F.; Ribatti, D.; Bussolino, F.; Guidolin, D.; Piaggio, G.; Bacigalupo, A.; Dammacco, F. Loss of inhibitory semaphorin3A (SEMA3A) autocrine loops in bone marrow endothelial cells ofpatients with multiple myeloma. Blood, 2006, 108, 1661-1667.